Ana Fernández Montés

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Teresa Mercade Macarulla · 2 shared papers, 2021–2025 · strength 0.29
   • Paper Real-world management and outcome of patients with pancreatic adenocarcinoma. Results of the Spanish RETUD gastrointest… DOI 10.1016/j.esmorw.2025.100116↗
   • Paper Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanc… DOI 10.1007/s00280-020-04214-w↗
2. Andrés Jesús Muñoz Martín · 1 shared paper, 2025 · strength 0.18
   • Paper Real-world management and outcome of patients with pancreatic adenocarcinoma. Results of the Spanish RETUD gastrointest… DOI 10.1016/j.esmorw.2025.100116↗
3. Ismael Ghanem · 1 shared paper, 2025 · strength 0.18
   • Paper Real-world management and outcome of patients with pancreatic adenocarcinoma. Results of the Spanish RETUD gastrointest… DOI 10.1016/j.esmorw.2025.100116↗
4. Florian Castet · 1 shared paper, 2025 · strength 0.18
   • Paper Real-world management and outcome of patients with pancreatic adenocarcinoma. Results of the Spanish RETUD gastrointest… DOI 10.1016/j.esmorw.2025.100116↗
5. Berta Laquente · 1 shared paper, 2025 · strength 0.18
   • Paper Real-world management and outcome of patients with pancreatic adenocarcinoma. Results of the Spanish RETUD gastrointest… DOI 10.1016/j.esmorw.2025.100116↗
6. Roberto Pazo-Cid · 1 shared paper, 2025 · strength 0.18
   • Paper Real-world management and outcome of patients with pancreatic adenocarcinoma. Results of the Spanish RETUD gastrointest… DOI 10.1016/j.esmorw.2025.100116↗
7. Alfredo Carrato Mena · 1 shared paper, 2025 · strength 0.18
   • Paper Real-world management and outcome of patients with pancreatic adenocarcinoma. Results of the Spanish RETUD gastrointest… DOI 10.1016/j.esmorw.2025.100116↗
8. Eva Martínez de Castro · 1 shared paper, 2025 · strength 0.18
   • Paper Real-world management and outcome of patients with pancreatic adenocarcinoma. Results of the Spanish RETUD gastrointest… DOI 10.1016/j.esmorw.2025.100116↗
9. Enrique Aranda Aguilar · 1 shared paper, 2025 · strength 0.18
   • Paper Real-world management and outcome of patients with pancreatic adenocarcinoma. Results of the Spanish RETUD gastrointest… DOI 10.1016/j.esmorw.2025.100116↗
10. Mónica Jorge Fernández · 2 shared papers, 2017–2021 · strength 0.18
    • Paper Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanc… DOI 10.1007/s00280-020-04214-w↗
    • Paper Prognostic and predictive markers of response to treatment in patients with locally advanced unresectable and metastati… DOI 10.4103/0973-1482.181181↗
11. Guillermo López-Vivanco · 1 shared paper, 2021 · strength 0.11
    • Paper Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanc… DOI 10.1007/s00280-020-04214-w↗
12. Jaime Feliú · 1 shared paper, 2021 · strength 0.11
    • Paper Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanc… DOI 10.1007/s00280-020-04214-w↗
13. Ana María López Muñoz · 1 shared paper, 2021 · strength 0.11
    • Paper Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanc… DOI 10.1007/s00280-020-04214-w↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.